MedPath

The effect of whole body vibration on patients with diabetic sarcopenia

Not Applicable
Recruiting
Conditions
Condition 1: Sarcopenia. Condition 2: Type 2 diabetes.
Sarcopenia
Type 2 diabetes mellitus
M62.84
Registration Number
IRCT20201128049511N6
Lead Sponsor
niversity of Tarbiat Modares
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

At least 6 months history of diabetes
Diagnosis of sarcopenia in people with diabetes
Score less than 13 on Michigan Neuropathy Screening Instrument
Normal Vitamin D level
t-score above -2.5

Exclusion Criteria

Having thyroid disorders
GFR score above 30
History of acute ischemia such as infarction in less than 3 months
History of falling in the past year
Taking drugs and supplements that have known effects on the neuromuscular system (such as corticosteroids)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ground Reaction Force Parameters. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Force plate device.;Fasting blood sugar (FBS). Timepoint: Before and after 8 weeks of intervention. Method of measurement: Blood test.;Quality of Life Index. Timepoint: Before and after 8 weeks of interventions. Method of measurement: SarQoL questionnaire.;Parameters of the body sway. Timepoint: before and after 8 weeks of intervention. Method of measurement: Force plate.;Three month blood sugar(hbA1C). Timepoint: before and after 8 weeks of intervention. Method of measurement: Blood test.;Inter Lucien 6 (IL-6). Timepoint: before and after 8 weeks of intervention. Method of measurement: Blood test.;Tumor necrosis factor alpha(TNF-a). Timepoint: before and after 8 weeks of intervention. Method of measurement: Blood test.;High-sensitivity C-reactive protein (hsCRP). Timepoint: before and after 8 weeks of intervention. Method of measurement: Blood test.
Secondary Outcome Measures
NameTimeMethod
Muscle strength. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Dynamometer.;Triglyceride. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Blood test.;Cholesterol. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Blood test.;Low-density lipoprotein(LDL). Timepoint: Before and after 8 weeks of intervention. Method of measurement: Blood test.;High-density lipoprotein(HDL). Timepoint: Before and after 8 weeks of intervention. Method of measurement: Blood test.
© Copyright 2025. All Rights Reserved by MedPath